REGIMEN FOR SKIN INFECTIONS

Article

New data suggest InterMune Inc.'s intravenous oritavancin is as effective as a regimen of vancomycin plus cephalexin in treating patients with complicated skin and skin-structure infections (CSSSI).

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.